Yin Qiao San
Natural health product licensed in Canada
- Licence holder
- Hummingbird Medical Tech Inc.
- NPN or DIN-HM
- 80051449
- Status
- Active licence
- Licence date
- 5 June 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Platycodon grandiflorus (Jacq.) A.DC.: L'étiquetage doit comporter un avertissement déconseillant un usage prolongé, tel que "L'usage prolongé peut irriter l'estomac".
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Forsythia suspensa Source : Fruit Extraction ratio : 5.8:1 Dry plant equivalent : 334 mg | 58 mg | Not calculated |
| Arctium lappa Source : Fruit Extraction ratio : 5.8:1 Dry plant equivalent : 200 mg | 34 mg | Not calculated |
| Glycyrrhiza uralensis Source : Rhizome et racine(s) Extraction ratio : 5.8:1 Dry plant equivalent : 167 mg | 29 mg | Not calculated |
| Platycodon grandiflorus Source : Racine Extraction ratio : 5.8:1 Dry plant equivalent : 200 mg | 34 mg | Not calculated |
| Lonicera japonica Source : Fleur Extraction ratio : 5.8:1 Dry plant equivalent : 334 mg | 58 mg | Not calculated |
| Mentha canadensis Source : Feuille Extraction ratio : 5.8:1 Dry plant equivalent : 200 mg | 34 mg | Not calculated |
| Lophatherum gracile Source : Feuille Extraction ratio : 5.8:1 Dry plant equivalent : 134 mg | 23 mg | Not calculated |
| Schizonepeta tenuifolia Source : Tige(s) Extraction ratio : 5.8:1 Dry plant equivalent : 134 mg | 23 mg | Not calculated |
| Schizonepeta tenuifolia Source : Bourgeon floral Extraction ratio : 5.8:1 Dry plant equivalent : 134 mg | 23 mg | Not calculated |
| Glycine max Source : Graine(s) Extraction ratio : 5.8:1 Dry plant equivalent : 167 mg | 29 mg | Not calculated |
| Phragmites australis Source : Rhizome Extraction ratio : 5.8:1 Dry plant equivalent : 67 mg | 12 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Chinese Medicine to release the exterior and clear toxic heat.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80051449
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.